About
Technology
Issues
FAQ
Links
Official Page
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.